Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Hemogram-derived ratios as prognostic markers of ICU admission in COVID-19.

Tytuł:
Hemogram-derived ratios as prognostic markers of ICU admission in COVID-19.
Autorzy:
Velazquez S; Anaesthesia Department, Hospital Universitario HM Sanchinarro, Madrid, Spain.; Anaesthesia Department, Hospital Universitario Santa Cristina, Madrid, Spain.; Fundación de Investigación HM Hospitales, Madrid, Spain.; Facultad de Medicina, Universidad CEU San Pablo, Madrid, Spain.
Madurga R; Fundación de Investigación HM Hospitales, Madrid, Spain.; Faculty of Experimental Sciences, Universidad Francisco de Vitoria, Madrid, Spain.
Castellano JM; Fundación de Investigación HM Hospitales, Madrid, Spain.; Facultad de Medicina, Universidad CEU San Pablo, Madrid, Spain.; Cardiology Department, Hospital Universitario HM Montepríncipe, Madrid, Spain.; Centro Nacional de Investigaciones Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain.
Rodriguez-Pascual J; Fundación de Investigación HM Hospitales, Madrid, Spain.; Oncology Department, HM-CIOCC, Hospital Universitario HM Puerta del Sur, Móstoles, Madrid, Spain.
de Aguiar Diaz Obregon SR; Fundación de Investigación HM Hospitales, Madrid, Spain.; Medical Management, Grupo HM Hospitales, Madrid, Spain.
Jimeno S; Fundación de Investigación HM Hospitales, Madrid, Spain.; Facultad de Medicina, Universidad CEU San Pablo, Madrid, Spain.; Pediatrics Department, Hospital Universitario HM Puerta del Sur, Móstoles, Madrid, Spain.
Montero JI; Intensive Care Unit, Hospital Universitario HM Puerta del Sur, Móstoles, Madrid, Spain.
Wichner PSV; Fundación de Investigación HM Hospitales, Madrid, Spain.; Pediatrics Department, Hospital Universitario HM Nens, Barcelona, Spain.; Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol, Barcelona, Spain.
López-Escobar A; Fundación de Investigación HM Hospitales, Madrid, Spain. .; Unidad de Investigación Clínica, Fundación Vithas. Grupo Vithas, Madrid, Spain. .; Pediatrics Department, Hospital Vithas Madrid La Milagrosa, Madrid, Spain. .
Źródło:
BMC emergency medicine [BMC Emerg Med] 2021 Jul 27; Vol. 21 (1), pp. 89. Date of Electronic Publication: 2021 Jul 27.
Typ publikacji:
Journal Article; Observational Study
Język:
English
Imprint Name(s):
Original Publication: London : BioMed Central, [2001-
MeSH Terms:
Intensive Care Units*
Severity of Illness Index*
COVID-19/*blood
Adult ; Biomarkers/blood ; COVID-19/immunology ; Humans ; Lymphocyte Count ; Male ; Middle Aged ; Neutrophils/immunology ; Platelet Count/methods ; Prognosis ; Retrospective Studies
References:
Lancet. 2020 Feb 22;395(10224):565-574. (PMID: 32007145)
J Infect. 2020 Jul;81(1):e6-e12. (PMID: 32283162)
N Engl J Med. 2020 Apr 30;382(18):1708-1720. (PMID: 32109013)
N Engl J Med. 2012 Nov 8;367(19):1814-20. (PMID: 23075143)
Pol Arch Intern Med. 2020 May 29;130(5):400-406. (PMID: 32356642)
J Transl Med. 2020 May 20;18(1):206. (PMID: 32434518)
J Clin Invest. 2020 May 1;130(5):2202-2205. (PMID: 32217834)
Eur J Clin Invest. 2021 Jan;51(1):e13404. (PMID: 32918295)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Int Immunopharmacol. 2020 Jul;84:106504. (PMID: 32304994)
Cell Mol Life Sci. 2015 Jul;72(14):2627-43. (PMID: 25650236)
J Med Virol. 2020 Sep;92(9):1533-1541. (PMID: 32181903)
Lancet. 2020 Mar 28;395(10229):1033-1034. (PMID: 32192578)
JAMA. 2020 Apr 28;323(16):1574-1581. (PMID: 32250385)
Inflammopharmacology. 2020 Aug;28(4):819-829. (PMID: 32227261)
Clin Cancer Res. 2014 Dec 1;20(23):6212-22. (PMID: 25271081)
Respirology. 2018 Feb;23(2):130-137. (PMID: 29052924)
N Engl J Med. 2003 May 15;348(20):1967-76. (PMID: 12690091)
Cell Tissue Res. 2018 Mar;371(3):567-576. (PMID: 29178039)
Crit Rev Oncol Hematol. 2013 Oct;88(1):218-30. (PMID: 23602134)
JAMA. 2012 Jun 20;307(23):2526-33. (PMID: 22797452)
J Investig Med. 2021 Jun;69(5):962-969. (PMID: 33849952)
Diagnostics (Basel). 2021 Mar 26;11(4):. (PMID: 33810534)
Aliment Pharmacol Ther. 2019 Aug;50(4):442-453. (PMID: 31313853)
Cancer Cell Int. 2020 Jun 9;20:224. (PMID: 32528232)
Pathogens. 2020 Jun 20;9(6):. (PMID: 32575786)
Contributed Indexing:
Keywords: COVID-19; Hemogram; Hemogram-derived ratio; ICU admission; Neutrophil-to-lymphocyte ratio; Neutrophil-to-platelet ratio
Substance Nomenclature:
0 (Biomarkers)
Entry Date(s):
Date Created: 20210728 Date Completed: 20210816 Latest Revision: 20210816
Update Code:
20240105
PubMed Central ID:
PMC8314257
DOI:
10.1186/s12873-021-00480-w
PMID:
34315437
Czasopismo naukowe
Background: The vast impact of COVID-19 call for the identification of clinical parameter that can help predict a torpid evolution. Among these, endothelial injury has been proposed as one of the main pathophysiological mechanisms underlying the disease, promoting a hyperinflammatory and prothrombotic state leading to worse clinical outcomes. Leukocytes and platelets play a key role in inflammation and thrombogenesis, hence the objective of the current study was to study whether neutrophil-to-lymphocyte ratio (NLR), platelets-to-lymphocyte ratio (PLR), the systemic immune-inflammation index (SII) as well as the new parameter neutrophil-to-platelet ratio (NPR), could help identify patients who at risk of admission at Intensive Care Units.
Methods: A retrospective observational study was performed at HM Hospitales including electronic health records from 2245 patients admitted due to COVID-19 from March 1 to June 10, 2020. Patients were divided into two groups, admitted at ICU or not.
Results: Patients who were admitted at the ICU had significantly higher values in all hemogram-derived ratios at the moment of hospital admission compared to those who did not need ICU admission. Specifically, we found significant differences in NLR (6.9 [4-11.7] vs 4.1 [2.6-7.6], p <  0.0001), PLR (2 [1.4-3.3] vs 1.9 [1.3-2.9], p = 0.023), NPR (3 [2.1-4.2] vs 2.3 [1.6-3.2], p <  0.0001) and SII (13 [6.5-25.7] vs 9 [4.9-17.5], p <  0.0001) compared to those who did not require ICU admission. After multivariable logistic regression models, NPR was the hemogram-derived ratio with the highest predictive value of ICU admission, (OR 1.11 (95% CI: 0.98-1.22, p = 0.055).
Conclusions: Simple, hemogram-derived ratios obtained from early hemogram at hospital admission, especially the novelty NPR, have shown to be useful predictors of risk of ICU admission in patients hospitalized due to COVID-19.
(© 2021. The Author(s).)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies